Three New Promising Treatments for Treating Lethal Melanoma

What's the News: Three new drugs have been shown to improve survival and slow disease progress in patients with metastatic melanoma. This advanced form of the disease is the deadliest type of skin cancer, with patients surviving for an average of only 6 to 9 months. Phase III clinical trials of the treatments---a new chemotherapy drug, an immune-system treatment combined with traditional chemotherapy, and a vaccine combined with another immune treatment---were recently published in the New England Journal of Medicine.New Chemotherapy Drug: